Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion
Rashmi Chandra, … , Neil J. Freedman, Rodger A. Liddle
Rashmi Chandra, … , Neil J. Freedman, Rodger A. Liddle
Published July 25, 2013
Citation Information: J Clin Invest. 2013;123(8):3343-3352. https://doi.org/10.1172/JCI68587.
View: Text | PDF
Research Article Gastroenterology

Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion

  • Text
  • PDF
Abstract

Cholecystokinin (CCK) is a satiety hormone produced by discrete enteroendocrine cells scattered among absorptive cells of the small intestine. CCK is released into blood following a meal; however, the mechanisms inducing hormone secretion are largely unknown. Ingested fat is the major stimulant of CCK secretion. We recently identified a novel member of the lipoprotein remnant receptor family known as immunoglobulin-like domain containing receptor 1 (ILDR1) in intestinal CCK cells and postulated that this receptor conveyed the signal for fat-stimulated CCK secretion. In the intestine, ILDR1 is expressed exclusively in CCK cells. Orogastric administration of fatty acids elevated blood levels of CCK in wild-type mice but not Ildr1-deficient mice, although the CCK secretory response to trypsin inhibitor was retained. The uptake of fluorescently labeled lipoproteins in ILDR1-transfected CHO cells and release of CCK from isolated intestinal cells required a unique combination of fatty acid plus HDL. CCK secretion secondary to ILDR1 activation was associated with increased [Ca2+]i, consistent with regulated hormone release. These findings demonstrate that ILDR1 regulates CCK release through a mechanism dependent on fatty acids and lipoproteins and that absorbed fatty acids regulate gastrointestinal hormone secretion.

Authors

Rashmi Chandra, Yu Wang, Rafiq A. Shahid, Steven R. Vigna, Neil J. Freedman, Rodger A. Liddle

×

Figure 6

Effects of fatty acids and lipoproteins on intracellular calcium fluorescence in CCK cells.

Options: View larger image (or click on image) Download as PowerPoint
Effects of fatty acids and lipoproteins on intracellular calcium fluores...
CCK-EGFP cells were isolated from the intestines of wild-type CCK-EGFP and Ildr1–/– CCK-EGFP mice and enriched by FACS. Cells were loaded with calcium-sensitive dye (X-rhod-1) and incubated first with lipoproteins (100 μg protein/ml) or C12 (100 μM), followed by lipoprotein plus C12, and finally with KCl (50 mM). (A) The responses of representative wild-type CCK-EGFP or Ildr1–/– CCK-EGFP cells to lipoproteins and lipoprotein plus C12 are shown. Change in fluorescence from green to yellow to red indicates elevation in [Ca2+]i. An increase in [Ca2+]i with KCl was used to confirm the viability of cells at the conclusion of each experiment. Results are representative of at least 3 experiments. (B) Change in fluorescence intensity in wild-type CCK-EGFP and Ildr1–/– CCK-EGFP cells to C12 alone, HDL alone, HDL plus C12, and KCl. (C) Percentage of wild-type CCK-EGFP and Ildr1–/– CCK-EGFP cells that showed at least a 10% increase in Ca2+ fluorescence in response to HDL or HDL plus C12. The percentage of cells responding to C12 alone is represented by the dashed line. Scale bar: 5 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts